• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The black market for covid-19 antiviral drugs.

作者信息

Plata Gabriel G

机构信息

Washington, DC.

出版信息

BMJ. 2022 May 31;377:o1282. doi: 10.1136/bmj.o1282.

DOI:10.1136/bmj.o1282
PMID:35640944
Abstract
摘要

相似文献

1
The black market for covid-19 antiviral drugs.新冠抗病毒药物的黑市
BMJ. 2022 May 31;377:o1282. doi: 10.1136/bmj.o1282.
2
No magic pocket: Buying and selling on drug cryptomarkets in response to the COVID-19 pandemic and social restrictions.没有魔法口袋：应对新冠疫情和社会限制措施下药品暗网市场的买卖情况
Int J Drug Policy. 2020 Sep;83:102894. doi: 10.1016/j.drugpo.2020.102894. Epub 2020 Jul 31.
3
Accelerating regulation in response to COVID-19.加速应对 COVID-19 的监管。
Bull World Health Organ. 2020 Aug 1;98(8):514-515. doi: 10.2471/BLT.20.020820.
4
Market watch: upcoming market catalysts in Q4 2012.市场观察：2012年第四季度即将出现的市场催化剂。
Nat Rev Drug Discov. 2012 Oct;11(10):740. doi: 10.1038/nrd3856.
5
Audio Interview: Covid-19 Vaccination and the Omicron Variant.音频访谈：新冠疫苗接种与奥密克戎变异株
N Engl J Med. 2021 Dec 30;385(27):e102. doi: 10.1056/NEJMe2120098.
6
The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.COVID-19 大流行对格鲁吉亚非法药物供应、药物滥用者相关行为以及药物相关服务提供的影响：一项混合方法前瞻性队列研究的结果。
Harm Reduct J. 2022 Mar 9;19(1):25. doi: 10.1186/s12954-022-00601-z.
7
Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19.加快步伐：呼吁临床和定量药理学界为 COVID-19 加速治疗药物研发。
Clin Transl Sci. 2020 Jul;13(4):646-648. doi: 10.1111/cts.12824. Epub 2020 Jun 11.
8
Comparison of illicit drug-related presentations to the emergency department: Pre-COVID versus COVID.急诊科与非法药物相关就诊情况的比较：新冠疫情前与新冠疫情期间
Emerg Med Australas. 2020 Oct;32(5):901. doi: 10.1111/1742-6723.13597. Epub 2020 Aug 8.
9
Therapeutic Agents Against COVID-19 with Clinical Evidence.抗 COVID-19 的治疗药物：临床证据。
Curr Pharm Des. 2021;27(13):1608-1617. doi: 10.2174/1381612827666210114150951.
10
Bridging the Gap at Warp Speed - Delivering Options for Preventing and Treating Covid-19.以极快速度弥合差距——提供预防和治疗新冠病毒病的方案
N Engl J Med. 2020 Nov 12;383(20):1899-1901. doi: 10.1056/NEJMp2028535. Epub 2020 Sep 15.

引用本文的文献

1
Choosing and accessing COVID-19 treatment options: a qualitative study with patients, caregivers, and health care providers in Lebanon.选择和获取 COVID-19 治疗方案：黎巴嫩患者、护理人员和医疗保健提供者的定性研究。
Health Res Policy Syst. 2024 Mar 27;22(1):38. doi: 10.1186/s12961-024-01131-9.
2
Effectiveness of Omega-3 Fatty Acid Supplementation in Improving the Metabolic and Inflammatory Profiles of Mexican Adults Hospitalized with COVID-19.补充omega-3脂肪酸对改善因COVID-19住院的墨西哥成年人代谢和炎症状况的有效性。
Diseases. 2024 Jan 17;12(1):28. doi: 10.3390/diseases12010028.
3
Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial.
局部适度热疗治疗轻至中度新型冠状病毒肺炎（TherMoCoV研究）：一项随机对照试验
Front Med (Lausanne). 2023 Dec 22;10:1256197. doi: 10.3389/fmed.2023.1256197. eCollection 2023.
4
Molnupiravir as the COVID-19 panacea: false beliefs in low- and middle-income countries.莫努匹拉韦作为治疗新冠肺炎的万灵药：低收入和中等收入国家的错误观念
Pathog Glob Health. 2023 Sep;117(6):525-526. doi: 10.1080/20477724.2023.2232593. Epub 2023 Jul 3.
5
Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials.新型冠状病毒肺炎恢复期血浆门诊治疗以预防门诊住院：5 项随机试验的个体参与者数据的荟萃分析。
Clin Infect Dis. 2023 Jun 16;76(12):2077-2086. doi: 10.1093/cid/ciad088.
6
Use of traditional Chinese medicine for the treatment and prevention of COVID-19 and rehabilitation of COVID-19 patients: An evidence mapping study.中医药用于新型冠状病毒肺炎的治疗、预防及新型冠状病毒肺炎患者康复：一项证据图谱研究
Front Pharmacol. 2023 Jan 19;14:1069879. doi: 10.3389/fphar.2023.1069879. eCollection 2023.
7
Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics.尼马曲韦和 COVID-19：研发、药代动力学、临床疗效、耐药性、复发和药物经济学。
Int J Antimicrob Agents. 2023 Feb;61(2):106708. doi: 10.1016/j.ijantimicag.2022.106708. Epub 2023 Jan 2.
8
COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials.新冠康复者血浆门诊治疗预防门诊患者住院：来自五项随机试验个体参与者数据的荟萃分析
medRxiv. 2022 Dec 18:2022.12.16.22283585. doi: 10.1101/2022.12.16.22283585.
9
Molnupiravir: From Hope to Epic Fail?莫努匹韦：从希望到惨败？
Viruses. 2022 Nov 19;14(11):2560. doi: 10.3390/v14112560.
10
and computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-M inhibitors.新型合成羧酰胺连接的吡啶并吡咯并嘧啶作为SARS-CoV-2-M抑制剂的活性及计算研究
RSC Adv. 2022 Sep 22;12(41):26895-26907. doi: 10.1039/d2ra04015h. eCollection 2022 Sep 16.